2017
DOI: 10.22159/ajpcr.2017.v10i11.20034
|View full text |Cite
|
Sign up to set email alerts
|

Identification of Various Defects in Pharmaceutical Tablets Using Image Processing Techniques

Abstract: Objective: Our aim is to identify the damaged tablets from the manufacturing line using image processing techniques and remove them before packaging. Methods:The various problems posed during inspection are broken tablets, corner chips, black or other color spots in tablets, empty blisters (without one or more tablets or capsules), foreign particles/color variation in the tablets/capsules, improper sealing, etc., Image processing techniques will be used for defect detection. Results:Tablets are available in pa… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2018
2018
2018
2018

Publication Types

Select...
2
1

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(1 citation statement)
references
References 9 publications
0
1
0
Order By: Relevance
“…[12][13][14] Anticancer effects of SYRA were explored on A549 lung carcinoma cells and was found to show apoptotic effects with an IC 50 of 30 µm. 15 To date SYRA crystal structure is not elucidated and crystal engineering studies exploring modification of pharmaceutical properties for therapeutic improvements are not available in literature. This study was designed to develop synergistic and organoprotective multicomponent systems using SYRA with paracetamol, isoniazid, piracetam, levetiracetam, 5-fluoro uracil, pyrazinamide, nicotinamide (NCT) and urea (U) for application in the treatment of various diseases.…”
Section: Introductionmentioning
confidence: 99%
“…[12][13][14] Anticancer effects of SYRA were explored on A549 lung carcinoma cells and was found to show apoptotic effects with an IC 50 of 30 µm. 15 To date SYRA crystal structure is not elucidated and crystal engineering studies exploring modification of pharmaceutical properties for therapeutic improvements are not available in literature. This study was designed to develop synergistic and organoprotective multicomponent systems using SYRA with paracetamol, isoniazid, piracetam, levetiracetam, 5-fluoro uracil, pyrazinamide, nicotinamide (NCT) and urea (U) for application in the treatment of various diseases.…”
Section: Introductionmentioning
confidence: 99%